|
Daily Medical Update
Carotid stenosis
Wednesday, July 15, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
The New England Journal of Medicine (2025) - Randomized Controlled Trial
Key Findings
- In the stenting trial, 4-year primary-outcome events occurred in 6.0% with intensive medical therapy alone versus 2.8% with stenting plus intensive medical therapy.
- In the endarterectomy trial, 4-year primary-outcome events were 5.3% with intensive medical therapy alone versus 3.7% with endarterectomy, a nonsignificant difference.
📋 Practice Implication: For high-grade asymptomatic stenosis, stenting may offer incremental stroke prevention in selected patients, while endarterectomy should be weighed more cautiously against modern medical therapy.
|
Journal of Neurology (2026) - Meta-Analysis of Randomized Controlled Trials
Key Findings
- Across SPACE-2, ECST-2, and CREST-2, the composite stroke/death outcome did not significantly differ between revascularization and medical management (4.76% vs 6.40%; RR 0.91, 95% CI 0.47-1.74).
- All-cause mortality was also similar between revascularization and medical management (7.7% vs 9.50%; RR 0.83, 95% CI 0.67-1.04).
📋 Practice Implication: For many asymptomatic patients, the evidence supports optimizing statins, antithrombotic therapy, blood pressure, and lifestyle before referral for prophylactic intervention.
|
Journal of Vascular Surgery (2025) - Systematic Review and Meta-Analysis
Key Findings
- Type VI plaques on 3.0 T MRA-VWI were strongly associated with symptomatic presentation (pooled OR 5.03, 95% CI 3.22-7.85).
- Vulnerable plaque features predicted first-ever ipsilateral events, with type VI plaque hazard ratio 3.61 and intraplaque hemorrhage hazard ratio 3.51 across field strengths.
📋 Practice Implication: In patients with moderate or uncertain-risk carotid disease, vessel-wall MRI can refine stroke-risk assessment when luminal stenosis alone does not explain symptoms or risk.
|
Journal of the American Heart Association (2026) - Secondary Analysis of Randomized Trial
Key Findings
- Among internal carotid arteries with nonstenotic disease, 27.4% were associated with concordant ipsilateral strokes.
- Intraluminal thrombi, carotid webs, dissections, and rim sign were each significantly associated with concordant stroke, with adjusted odds ratios from 3.17 to 8.11.
📋 Practice Implication: Stroke evaluation should not dismiss carotid disease solely because stenosis is below 50%; high-risk plaque morphology can justify closer vascular or stroke specialist review.
|
Journal of NeuroInterventional Surgery (2026) - Systematic Review and Network Meta-Analysis
Key Findings
- Short-term stroke risk was significantly lower with CEA than with CAS, while TCAR showed a potential long-term mortality benefit over CAS.
- CAS had lower risks of cranial nerve injury, hematoma, and infection compared with CEA, with no significant short-term mortality or myocardial infarction differences across treatments.
📋 Practice Implication: When revascularization is pursued, procedural selection should be individualized: CEA remains favored for short-term stroke protection, while TCAR may be preferable to transfemoral CAS in selected anatomy or risk profiles.
|
|
💡
Summary
Recent carotid stenosis evidence continues to narrow management toward intensive medical therapy plus highly selective revascularization. CREST-2 suggests stenting can reduce 4-year composite stroke/death outcomes in high-grade asymptomatic disease, while contemporary syntheses emphasize comparable medical-therapy outcomes, procedural tradeoffs between CEA/CAS/TCAR, and the importance of plaque features beyond stenosis percentage.
|
|